Recursion Announces Pricing of $200 Million Public Offering of Class A Common StockGlobeNewsWire • 06/27/24
Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic DataBusiness Wire • 06/24/24
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download DayGlobeNewsWire • 06/24/24
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big ClaimThe Motley Fool • 06/07/24
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing ToolGlobeNewsWire • 05/29/24
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending StockZacks Investment Research • 05/23/24
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical IndustryGlobeNewsWire • 05/13/24